We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+8.13%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$453M
AUM Growth
+$37.4M
Cap. Flow
+$5.24M
Cap. Flow %
1.16%
Top 10 Hldgs %
22.62%
Holding
270
New
36
Increased
124
Reduced
34
Closed
42

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$6.18M
2
FTNT icon
Fortinet
FTNT
+$6.12M
3
MSCI icon
MSCI
MSCI
+$5.63M
4
MCO icon
Moody's
MCO
+$5.44M
5
MDLZ icon
Mondelez International
MDLZ
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 29.27%
2 Healthcare 16.12%
3 Financials 10.88%
4 Industrials 10.21%
5 Communication Services 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGYS icon
126
Agilysys
AGYS
$2.93B
$772K 0.17%
31,943
+2,316
+8% +$51.6K
SHW icon
127
Sherwin-Williams
SHW
$80.7B
$769K 0.17%
+3,312
New +$723K
MNTV
128
DELISTED
Momentive Global Inc. Common Stock
MNTV
$765K 0.17%
34,621
+6,667
+24% +$155K
RBC icon
129
RBC Bearings
RBC
$18.5B
$736K 0.16%
6,074
+246
+4% +$31.5K
ACN icon
130
Accenture
ACN
$95.1B
$694K 0.15%
3,070
+69
+2% +$15.8K
CRAI icon
131
CRA International
CRAI
$1.12B
$672K 0.15%
17,941
+430
+2% +$17.8K
TMO icon
132
Thermo Fisher Scientific
TMO
$208B
$561K 0.12%
1,270
+109
+9% +$45K
ABT icon
133
Abbott
ABT
$182B
$554K 0.12%
5,089
-405
-7% -$41.1K
EGRX
134
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$510K 0.11%
12,000
-12,000
-50% -$525K
GD icon
135
General Dynamics
GD
$105B
$501K 0.11%
3,616
-402
-10% -$59.4K
EBSB
136
DELISTED
Meridian Bancorp, Inc.
EBSB
$454K 0.1%
+28,130
New +$319K
ZTS icon
137
Zoetis
ZTS
$32.3B
$446K 0.1%
2,700
+76
+3% +$11.7K
WST icon
138
West Pharmaceutical
WST
$23.5B
$441K 0.1%
1,605
SNPS icon
139
Synopsys
SNPS
$74.7B
$436K 0.1%
2,038
+11
+0.5% +$2.24K
A icon
140
Agilent Technologies
A
$39B
$424K 0.09%
4,205
+118
+3% +$11.4K
ISRG icon
141
Intuitive Surgical
ISRG
$127B
$424K 0.09%
1,794
+57
+3% +$12.8K
IJH icon
142
iShares Core S&P Mid-Cap ETF
IJH
$123B
$411K 0.09%
11,080
-7,230
-39% -$270K
MA icon
143
Mastercard
MA
$487B
$405K 0.09%
1,199
-18
-1% -$5.85K
V icon
144
Visa
V
$689B
$403K 0.09%
2,014
+198
+11% +$39.5K
INTU icon
145
Intuit
INTU
$83.4B
$361K 0.08%
1,107
+37
+3% +$11.6K
VEA icon
146
Vanguard FTSE Developed Markets ETF
VEA
$227B
$355K 0.08%
8,672
-5,852
-40% -$240K
MORN icon
147
Morningstar
MORN
$6.95B
$350K 0.08%
2,180
+88
+4% +$13.9K
POOL icon
148
Pool Corp
POOL
$6.76B
$328K 0.07%
+980
New +$303K
VRTX icon
149
Vertex Pharmaceuticals
VRTX
$122B
$328K 0.07%
+1,204
New +$332K
ICE icon
150
Intercontinental Exchange
ICE
$83.8B
$326K 0.07%
3,256
-59
-2% -$5.82K

Similar funds

Stanley-Laman Group's Q3 2020 Portfolio in Review

As of Q3 2020, Stanley-Laman Group held 270 positions worth $453M, up 9% from $416M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Stanley-Laman Group's Q3 2020 filing shows 36 new, 124 increased, 34 reduced and 42 closed positions. Its largest new stake was Mondelez International: 45,792 shares worth $2.63M. The largest sale was Danaher, an estimated $6.71M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.

  • Stanley-Laman Group's largest Q3 2020 buy was Mondelez International: 45,792 shares worth $2.63M.
  • Stanley-Laman Group added most to S&P Global in Q3 2020, an estimated $6.18M increase.
  • Stanley-Laman Group's biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.86M.
  • Stanley-Laman Group fully exited Danaher in Q3 2020, selling an estimated $6.71M.
  • Stanley-Laman Group's ten largest holdings make up 23% of its $453M portfolio in Q3 2020.
  • Stanley-Laman Group opened 36 new positions and closed 42 in Q3 2020.
  • Stanley-Laman Group's portfolio value rose 9% quarter-over-quarter to $453M.

Based on Stanley-Laman Group's 13F filing for Q3 2020, filed 20 Oct 2020.